top of page

BackTable / Urology / Podcast / Episode #210

Personalizing ADT Across the Prostate Cancer Spectrum

with Dr. Rana McKay

What is the role of androgen deprivation therapy (ADT) in prostate cancer treatment? In this episode of the BackTable Urology Podcast, Dr. Rana McKay, a medical oncologist from UC San Diego, joins host Dr. Aditya Bagrodia to discuss the administration of ADT and other management strategies for prostate cancer.

This podcast is supported by:

Be part of the conversation. Put your sponsored messaging on this episode. Learn how.

Personalizing ADT Across the Prostate Cancer Spectrum with Dr. Rana McKay on the BackTable Urology Podcast)
Ep 210 Personalizing ADT Across the Prostate Cancer Spectrum with Dr. Rana McKay
00:00 / 01:04

BackTable, LLC (Producer). (2025, January 21). Ep. 210 – Personalizing ADT Across the Prostate Cancer Spectrum [Audio podcast]. Retrieved from https://www.backtable.com

Stay Up To Date

Follow:

Subscribe:

Sign Up:

Podcast Contributors

Dr. Rana McKay discusses Personalizing ADT Across the Prostate Cancer Spectrum on the BackTable 210 Podcast

Dr. Rana McKay

Dr. Rana McKay is a medical oncologist and associate professor at UC San Diego Health in California.

Dr. Aditya Bagrodia discusses Personalizing ADT Across the Prostate Cancer Spectrum on the BackTable 210 Podcast

Dr. Aditya Bagrodia

Dr. Aditya Bagrodia is an associate professor of urology and genitourinary oncology team leader at UC San Diego Health in California and adjunct professor of urology at UT Southwestern.

Synopsis

The doctors offer a historical perspective into the evolution of ADT over time and discuss the variety of different ADT treatment options available. They compare management strategies for localized and metastatic prostate cancer and discuss how to align therapy with patient goals, focusing on the side effects. The conversation also explores the impact of prostate-specific membrane antigen (PSMA) PET imaging on management and the future directions of hormonal therapies in urologic oncology.

Timestamps

00:00 - Introduction
05:25 - ADT Options
10:36 - Choosing an Agent and Managing Side Effects
26:42 - Continuous Versus Intermittent Therapy
30:30 - Closing Remarks

Resources

Disclaimer: The Materials available on BackTable.com are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.

backtable-plus-vi-cta.jpg
Become a BackTable Sponsor

Up Next

Management of Bladder Cancer: Insights from Community Practice with Dr. Guatam Jayram  on the BackTable Urology Podcast)
Integrating APPs into Men’s Health Practices with Kristen Gumpf and Dr. Alex Tatem on the BackTable Urology Podcast)
Integrating Clinical Trials into Routine Urology Practice with Dr. Behfar Ehdaie on the BackTable Urology Podcast)
Biochemical Recurrence: Insights from AUA/ASTRO/SUO Guidelines with Dr. Todd Morgan on the BackTable Urology Podcast)
Managing Low & Intermediate RIsk Bladder Cancer with Dr. Betsy Koehne and Dr. Amir Salmasi on the BackTable Urology Podcast)
Optimizing Bladder Health in BPH Treatment Strategies with Dr. Shawn West on the BackTable Urology Podcast)

Articles

Topics

Get in touch!

We want to hear from you. Let us know if you’re interested in partnering with BackTable as a Podcast guest, a sponsor, or as a member of the BackTable Team.

Select which show(s) you would like to subscribe to:

Thanks! Message sent.

bottom of page